The National Institute for Biotechnology
in the Negev Ltd.
Ben-Gurion University of the Negev

Research topicResearch FieldPrincipal Investigator
TRAMMICS: Target Receptor Activating Membrane Moiety with Inert Cytoplasmic Stub
Learn More
Neurodegenerative diseasesProfs. Angel Porgador, Alon Monsonego
Protein Life Extension Using Glycosylation Rich Sequences Learn MoreMetabolic diseasesProf. Angel Porgador
CARTIV: Chimeric Antigen Receptor Within Tumor-Induced Vector (Promoter-Based Targeting of CAR Expression to Tumor Site) Learn MoreCancerProf. Angel Porgador, Dr. Roi Gazit
Targeting Translation Inhibition to Inhibit Tumor Adaptation to Metabolic Stress Learn MoreCancerDr. Barak Rotblat
Developing A Novel Target Therapy for EGFR Mutated Lung Cancer Learn MoreCancerProf. Nir Peled
Dual-Specific R-Protein as an Anti-Resorptive Treatment for Bone-Related Disorders Learn MoreMetabolic diseasesProf. Niv Papo, Dr. Noam Levaot
Combinatorial Protein Engineering of Proteolytically Resistant Mesotrypsin Inhibitors for Cancer Therapy Learn MoreCancerProf. Niv Papo
Fortis: A New Rapid Screening Assay for Cognitive Enhancement Compounds Learn MoreNeurodegenerative diseasesDr. Shira Knafo
Deimmunization of Therapeutic Proteins Learn MorePlatformsProf. Amir Aharoni, Dr. Tomer Hertz
Rapid Diagnostic Assay for Antibody Dependent Enhancement Following Secondary Flaviviruses Infection Learn MorePlatformsDr. Tomer Hertz
Novel Profiling of Influenza Immune History: Implications on Vaccine-Induced Immunity and Efficacy Learn MorePlatformsDr. Tomer Hertz
Novel Biomarker Proteins for CLL and Lung Cancer: Impact on Diagnosis, Prognosis, and Treatment Learn MoreCancerProf. Varda Shoshan-Barmatz
Selective Induction of Cancer Cell Death by VDAC1-Based Peptides Learn MoreCancerProf. Varda Shoshan-Barmatz
New Anti-Cancer Therapeutic Strategies by Silencing SMAC/DIABLO Learn MoreCancerProf. Varda Shoshan-Barmatz
Compounds Targeting the Mitochondrial Protein VDAC1: A Therapeutic Strategy in Neurodegenerative Diseases Learn MoreNeurodegenerative diseasesProf. Varda Shoshan-Barmatz
Treating Cancer with VDAC1-Based siRNA; Reprograming Metabolism and Reversing Oncogenic Properties Learn MoreCancerProf. Varda Shoshan-Barmatz